LYSODREN

Approval Id: aea725586b11fa69
Drug Approval Canada Name: LYSODREN
Product Name: LYSODREN
Status: Marketed
Status Date: 2021-02-03
Original Market Date: 1979-12-31
Din: 00463221
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01XX23 MITOTANE
Atc Name: l 01 xx 23
Aig Number: 0113395001
Company Name: HRA Pharma Rare Diseases SAS
Company Address: 200 Avenue De Paris, Chatillon, Hauts-De-Seine, France, 92320
Company Detail Path: /organization/hra-pharma-rare-diseases-sas

MITOTANE

500 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

aea725586b11fa69

Type

Standard